The distribution of serogroups and multilocus sequence types (STs) in collections of disease-associated and carried meningococci from the period 1991 to 2000 in three European countries (the Czech Republic, Greece, and Norway) was investigated. A total of 314 patient isolates and 353 isolates from asymptomatic carriers were characterized. The frequency distributions of serogroups and clone complexes differed among countries and between disease and carrier isolate collections. Highly significant differentiation was seen at each housekeeping locus. A marked positive association of serogroup C with disease was evidenced. The ST-11 complex was strongly positively associated with disease; associations for other clone complexes were weaker. The genetic diversity of the clone complexes differed. A single ST dominated the ST-11 clone complex, while the ST-41/44 complex exhibited greater levels of diversity. These data robustly demonstrated differences in the distribution of meningococcal genotypes in disease and carrier isolates and among countries. Further, they indicated that differences in genotype diversity and pathogenicity exist between meningococcal clone complexes.

Department of Airborne Infections Division of Infectious Disease Control Norwegian Institute of Public Health P O Box 4404 Nydalen NO 0403 Oslo Norway

Zobrazit více v PubMed

Abdillahi, H., and J. T. Poolman. 1988. Typing of group-B Neisseria meningitidis with monoclonal antibodies in the whole-cell ELISA. J. Med. Microbiol. 26:177-180. PubMed

Andersen, J., L. Berthelsen, J. B. Bech, and I. Lind. 1998. Dynamics of the meningococcal carrier state and characteristics of the carrier strains: a longitudinal study within three cohorts of military recruits. Epidemiol. Infect. 121:85-94. PubMed PMC

Ashton, F. E., J. A. Ryan, A. Borczyk, D. A. Caugant, L. Mancino, and D. Huang. 1991. Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada. J. Clin. Microbiol. 29:2489-2493. PubMed PMC

Bevanger, L., K. Bergh, G. Gisnas, D. A. Caugant, and L. O. Frøholm. 1998. Identification of nasopharyngeal carriage of an outbreak strain of Neisseria meningitidis by pulsed-field gel electrophoresis versus phenotypic methods. J. Med. Microbiol. 47:993-998. PubMed

Broome, C. V. 1986. The carrier state: Neisseria meningitidis. J. Antimicrob. Chemother. 18(Suppl. A):25-34. PubMed

Cardenosa, N., A. Dominguez, A. Martinez, J. Alvarez, H. Panella, P. Godoy, S. Minguell, N. Camps, and J. A. Vazquez. 2003. Meningococcal disease in Catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine. Infection 31:392-397. PubMed

Cartwright, K. A., J. M. Stuart, D. M. Jones, and N. D. Noah. 1987. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol. Infect. 99:591-601. PubMed PMC

Caugant, D. A. 1998. Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS 106:505-525. PubMed

Caugant, D. A., P. Bol, E. A. Høiby, H. C. Zanen, and L. O. Frøholm. 1990. Clones of serogroup B Neisseria meningitidis causing systemic disease in The Netherlands, 1958-1986. J. Infect. Dis. 162:867-874. PubMed

Caugant, D. A., L. O. Frøholm, K. Bøvre, E. Holten, C. E. Frasch, L. F. Mocca, W. D. Zollinger, and R. K. Selander. 1986. Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc. Natl. Acad. Sci. USA 83:4927-4931. PubMed PMC

Caugant, D. A., E. A. Høiby, P. Magnus, O. Scheel, T. Hoel, G. Bjune, E. Wedege, J. Eng, and L. O. Frøholm. 1994. Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J. Clin. Microbiol. 32:323-330. PubMed PMC

Caugant, D. A., B. E. Kristiansen, L. O. Frøholm, K. Bøvre, and R. K. Selander. 1988. Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers. Infect. Immun. 56:2060-2068. PubMed PMC

Caugant, D. A., L. F. Mocca, C. E. Frasch, L. O. Frøholm, W. D. Zollinger, and R. K. Selander. 1987. Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J. Bacteriol. 169:2781-2792. PubMed PMC

Claus, H., M. C. Maiden, R. Maag, M. Frosch, and U. Vogel. 2002. Many carried meningococci lack the genes required for capsule synthesis and transport. Microbiology 148:1813-1819. PubMed

De Wals, P., G. De Serres, and T. Niyonsenga. 2001. Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec. JAMA 285:177-181. PubMed

Dolan-Livengood, J. M., Y. K. Miller, L. E. Martin, R. Urwin, and D. S. Stephens. 2003. Genetic basis for nongroupable Neisseria meningitidis. J. Infect. Dis. 187:1616-1628. PubMed

Edwards, E. A., L. F. Devine, G. H. Sengbusch, and H. W. Ward. 1977. Immunological investigations of meningococcal disease. III. Brevity of group C acquisition prior to disease occurrence. Scand. J. Infect. Dis. 9:105-110. PubMed

Enright, M. C., D. A. Robinson, G. Randle, E. J. Feil, H. Grundmann, and B. G. Spratt. 2002. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl. Acad. Sci. USA 99:7687-7692. PubMed PMC

Excoffier, L., P. E. Smouse, and J. M. Quattro. 1992. Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics 131:479-491. PubMed PMC

Feavers, I. M., S. J. Gray, R. Urwin, J. E. Russell, J. A. Bygraves, E. B. Kaczmarski, and M. C. Maiden. 1999. Multilocus sequence typing and antigen gene sequencing in the investigation of a meningococcal disease outbreak. J. Clin. Microbiol. 37:3883-3887. PubMed PMC

Feil, E., G. Carpenter, and B. G. Spratt. 1995. Electrophoretic variation in adenylate kinase of Neisseria meningitidis is due to inter- and intraspecies recombination. Proc. Natl. Acad. Sci. USA 92:10535-10539. PubMed PMC

Feil, E. J., M. C. Maiden, M. Achtman, and B. G. Spratt. 1999. The relative contributions of recombination and mutation to the divergence of clones of Neisseria meningitidis. Mol. Biol. Evol. 16:1496-1502. PubMed

Fernandez, S., L. Arreaza, I. Santiago, A. Malvar, S. Berron, J. A. Vazquez, X. Hervada, and J. J. Gestal. 1999. Carriage of a new epidemic strain of Neisseria meningitidis and its relationship with the incidence of meningococcal disease in Galicia, Spain. Epidemiol. Infect. 123:349-357. PubMed PMC

Greenwood, B. 1999. Meningococcal meningitis in Africa. Trans. R. Soc. Trop. Med. Hyg. 93:341-353. PubMed

Greiner, O., C. Berger, P. J. Day, G. Meier, C. M. Tang, and D. Nadal. 2002. Rates of detection of Neisseria meningitidis in tonsils differ in relation to local incidence of invasive disease. J. Clin. Microbiol. 40:3917-3921. PubMed PMC

Hammerschmidt, S., R. Hilse, J. P. van Putten, R. Gerardy-Schahn, A. Unkmeir, and M. Frosch. 1996. Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element. EMBO J. 15:192-198. PubMed PMC

Hammerschmidt, S., A. Muller, H. Sillmann, M. Muhlenhoff, R. Borrow, A. Fox, J. vanPutten, W. D. Zollinger, R. Gerardy-Schahn, and M. Frosch. 1996. Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease. Mol. Microbiol. 20:1211-1220. PubMed

Holmes, E. C., R. Urwin, and M. C. Maiden. 1999. The influence of recombination on the population structure and evolution of the human pathogen Neisseria meningitidis. Mol. Biol. Evol. 16:741-749. PubMed

Jolley, K. A., E. J. Feil, M. S. Chan, and M. C. Maiden. 2001. Sequence type analysis and recombinational tests (START). Bioinformatics 17:1230-1231. PubMed

Jolley, K. A., J. Kalmusova, E. J. Feil, S. Gupta, M. Musilek, P. Kriz, and M. C. Maiden. 2000. Carried meningococci in the Czech Republic: a diverse recombining population. J. Clin. Microbiol. 38:4492-4498. PubMed PMC

Kahler, C. M., L. E. Martin, G. C. Shih, M. M. Rahman, R. W. Carlson, and D. S. Stephens. 1998. The (alpha2→8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum. Infect. Immun. 66:5939-5947. PubMed PMC

Kellerman, S. E., K. McCombs, M. Ray, W. Baughman, M. W. Reeves, T. Popovic, N. E. Rosenstein, M. M. Farley, P. Blake, and D. S. Stephens. 2002. Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease. J. Infect. Dis. 186:40-48. PubMed

Kremastinou, J., G. Tzanakaki, A. Kansouzidou, A. Pagalis, V. Danielides, G. Kouppari, E. Lada, P. Kriz, M. Musilek, D. M. Weir, and C. C. Blackwell. 1999. Recent emergence of serogroup C meningococcal disease in Greece. FEMS Immunol. Med. Microbiol. 23:49-55. PubMed

Kremastinou, J., G. Tzanakaki, S. Levidiotou, F. Markou, E. Themeli, A. Voyiatzi, E. Psoma, M. Theodoridou, and C. C. Blackwell. 2003. Carriage of Neisseria meningitidis and Neisseria lactamica in northern Greece. FEMS Immunol. Med. Microbiol. 39:23-29. PubMed

Kriz, P., D. Giorgini, M. Musilek, M. Larribe, and M. K. Taha. 1999. Microevolution through DNA exchange among strains of Neisseria meningitidis isolated during an outbreak in the Czech Republic. Res. Microbiol. 150:273-280. PubMed

Krizova, P., and M. Musilek. 1995. Changing epidemiology of meningococcal invasive disease in the Czech Republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37. Cent. Eur. J. Public Health 3:189-194. PubMed

Krizova, P., M. Musilek, and J. Kalmusova. 1997. Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37. Cent. Eur. J. Public Health 5:214-218. PubMed

Linz, B., M. Schenker, P. Zhu, and M. Achtman. 2000. Frequent interspecific genetic exchange between commensal neisseriae and Neisseria meningitidis. Mol. Microbiol. 36:1049-1058. PubMed

Mackinnon, F. G., R. Borrow, A. R. Gorringe, A. J. Fox, D. M. Jones, and A. Robinson. 1993. Demonstration of lipooligosaccharide immunotype and capsule as virulence factors for Neisseria meningitidis using an infant mouse intranasal infection model. Microb. Pathog. 15:359-366. PubMed

MacLennan, J. M., R. Urwin, S. Obaro, D. Griffiths, B. Greenwood, and M. C. Maiden. 2000. Carriage of serogroup W-135, ET-37 meningococci in The Gambia: implications for immunisation policy? Lancet 356:1078. PubMed

Maiden, M. C., J. A. Bygraves, E. Feil, G. Morelli, J. E. Russell, R. Urwin, Q. Zhang, J. Zhou, K. Zurth, D. A. Caugant, I. M. Feavers, M. Achtman, and B. G. Spratt. 1998. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. USA 95:3140-3145. PubMed PMC

Maiden, M. C., and B. G. Spratt. 1999. Meningococcal conjugate vaccines: new opportunities and new challenges. Lancet 354:615-616. PubMed

Mayer, L. W., M. W. Reeves, N. Al Hamdan, C. T. Sacchi, M. K. Taha, G. W. Ajello, S. E. Schmink, C. A. Noble, M. L. Tondella, A. M. Whitney, Y. Al Mazrou, M. Al Jefri, A. Mishkhis, S. Sabban, D. A. Caugant, J. Lingappa, N. E. Rosenstein, and T. Popovic. 2002. Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. J. Infect. Dis. 185:1596-1605. PubMed

Miller, E., D. Salisbury, and M. Ramsay. 2001. Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine 20(Suppl. 1):S58-S67. PubMed

Moore, P. S., M. W. Reeves, B. Schwartz, B. G. Gellin, and C. V. Broome. 1989. Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet ii:260-263. PubMed

Olyhoek, T., B. A. Crowe, and M. Achtman. 1987. Clonal population structure of Neisseria meningitidis serogroup A isolated from epidemics and pandemics between 1915 and 1983. Rev. Infect. Dis. 9:665-692. PubMed

Patrick, D. M., S. Champagne, S. H. Goh, G. Arsenault, E. Thomas, C. Shaw, T. Rahim, F. Taha, M. Bigham, V. Dubenko, D. Skowronski, and R. C. Brunham. 2003. Neisseria meningitidis carriage during an outbreak of serogroup C disease. Clin. Infect. Dis. 37:1183-1188. PubMed

Peltola, H. 1983. Meningococcal disease: still with us. Rev. Infect. Dis. 5:71-91. PubMed

Rosenstein, N. E., B. A. Perkins, D. S. Stephens, L. Lefkowitz, M. L. Cartter, R. Danila, P. Cieslak, K. A. Shutt, T. Popovic, A. Schuchat, L. H. Harrison, and A. L. Reingold. 1999. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J. Infect. Dis. 180:1894-1901. PubMed

Rosenstein, N. E., B. A. Perkins, D. S. Stephens, T. Popovic, and J. M. Hughes. 2001. Meningococcal disease. N. Engl. J. Med. 344:1378-1388. PubMed

Rozas, J., J. C. Sanchez-DelBarrio, X. Messeguer, and R. Rozas. 2003. DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 19:2496-2497. PubMed

Salleras, L., A. Dominguez, and N. Cardenosa. 2003. Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain. Vaccine 21:725-728. PubMed

Schneider, S., D. Rossli, and L. Excoffier. 2000. Arlequin version 2.00: a software for population genetic data analysis. University of Genoa, Genoa, Italy.

Schwartz, B., P. S. Moore, and C. V. Broome. 1989. Global epidemiology of meningococcal disease. Clin. Microbiol. Rev. 2:S118-S124. PubMed PMC

Stephens, D. S. 1999. Uncloaking the meningococcus: dynamics of carriage and disease. Lancet 353:941-942. PubMed

Swartley, J. S., J. H. Ahn, L. J. Liu, C. M. Kahler, and D. S. Stephens. 1996. Expression of sialic acid and polysialic acid in serogroup B Neisseria meningitidis: divergent transcription of biosynthesis and transport operons through a common promoter region. J. Bacteriol. 178:4052-4059. PubMed PMC

Swartley, J. S., A. A. Marfin, S. Edupuganti, L. J. Liu, P. Cieslak, B. Perkins, J. D. Wenger, and D. S. Stephens. 1997. Capsule switching of Neisseria meningitidis. Proc. Natl. Acad. Sci. USA 94:271-276. PubMed PMC

Tzeng, Y. L., and D. S. Stephens. 2000. Epidemiology and pathogenesis of Neisseria meningitidis. Microbes Infect. 2:687-700. PubMed

Urwin, R., and M. C. Maiden. 2003. Multi-locus sequence typing: a tool for global epidemiology. Trends Microbiol. 11:479-487. PubMed

Vedros, N. A. 1987. Development of meningococcal serogroups, p. 33-37. In N. A. Vedros (ed.), Evolution of meningococcal disease. CRC Press Inc., Boca, Raton Fla.

Vieusseux, G. 1805. Mémoire sur la maladie qui a régné à Genève au printemps de 1805. Journal de Medecine, Chirurgie et Pharmacie II:163-165.

Vogel, U., H. Claus, and M. Frosch. 2000. Rapid serogroup switching in Neisseria meningitidis. N. Engl. J. Med. 342:219-220. PubMed

Vogel, U., H. Claus, M. Frosch, and D. A. Caugant. 2000. Molecular basis for distinction of the ET-15 clone within the ET-37 complex of Neisseria meningitidis. J. Clin. Microbiol. 38:941-942. PubMed PMC

Vogel, U., and M. Frosch. 1999. Mechanisms of neisserial serum resistance. Mol. Microbiol. 32:1133-1139. PubMed

Wang, J. F., D. A. Caugant, X. Li, X. Hu, J. T. Poolman, B. A. Crowe, and M. Achtman. 1992. Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China. Infect. Immun. 60:5267-5282. PubMed PMC

Wedege, E., E. A. Høiby, E. Rosenqvist, and L. O. Frøholm. 1990. Serotyping and subtyping of Neisseria meningitidis isolates by co-agglutination, dot-blotting and ELISA. J. Med. Microbiol. 31:195-201. PubMed

Wenzel, R. P., J. A. Davies, J. R. Mitzel, and W. E. Beam, Jr. 1973. Non-usefulness of meningococcal carriage-rates. Lancet ii:205. PubMed

Wright, S. 1951. The genetical structure of populations. Ann. Augenics 15:323-354. PubMed

Wright, S. 1969. Evolution and the genetics of populations, vol. 2, p. 290-344. University of Chicago Press, Chicago, Ill.

Serogroup and Clonal Characterization of Czech Invasive Neisseria meningitidis Strains Isolated from 1971 to 2015

Exploring the population-level impact of MenB vaccination via modeling: Potential for serogroup replacement

Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development

Long-term evolution of antigen repertoires among carried meningococci

Role of selection in the emergence of lineages and the evolution of virulence in Neisseria meningitidis